Such meaningful immune responses, able to control or eradicate tumour growth, have been characterised by the generation of potent tumour antigen specific CD4+, CD8+ T-cells and B-cells in the tumour microenvironment [4,5]. This evidence concerns the gene CD8A and neoplasm.